000 | 01151 a2200325 4500 | ||
---|---|---|---|
005 | 20250515104830.0 | ||
264 | 0 | _c20080321 | |
008 | 200803s 0 0 eng d | ||
022 | _a1567-2050 | ||
024 | 7 |
_a10.2174/156720507783018343 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWindisch, Manfred | |
245 | 0 | 0 |
_aIs alpha-synuclein pathology a target for treatment of neurodegenerative disorders? _h[electronic resource] |
260 |
_bCurrent Alzheimer research _cDec 2007 |
||
300 |
_a556-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
650 | 0 | 4 |
_aNeuroprotective Agents _xchemistry |
650 | 0 | 4 | _aPeptide Library |
650 | 0 | 4 |
_aPeptides _xtherapeutic use |
650 | 0 | 4 |
_aalpha-Synuclein _xchemistry |
700 | 1 | _aWolf, Hans-Jörg | |
700 | 1 | _aHutter-Paier, Birgit | |
700 | 1 | _aWronski, Robert | |
773 | 0 |
_tCurrent Alzheimer research _gvol. 4 _gno. 5 _gp. 556-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/156720507783018343 _zAvailable from publisher's website |
999 |
_c17727758 _d17727758 |